The invention relates to novel piperazine compounds; to processes for their preparation; to pharmaceutical compositions containing the compounds; and to the use of the compounds in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial, i.e. in particular to treat pain.
这项发明涉及新型
哌嗪化合物;它们的制备方法;含有这些化合物的药物组合物;以及利用这些化合物在治疗中阻断Cav2.2
钙通道对有益的疾病进行治疗,即特别用于治疗疼痛。